|
Market Closed -
Sao Paulo
02:56:46 2026-09-08 pm EDT
|
5-day change | 1st Jan Change | ||
| 84.20 BRL | -85.47% |
|
-4.24% | +7.62% |
| Market Cap | 134B 681B 115B 108B 98.96B 185B 12,709B 186B 1,285B 497B 6,496B 503B 492B 20,671B | P/E 2026 * |
54.4x | P/E 2027 * | 28.7x |
|---|---|---|---|---|---|
| Enterprise Value | 129B 655B 111B 104B 95.04B 177B 12,206B 178B 1,234B 477B 6,239B 483B 473B 19,854B | EV / Sales 2026 * |
9.72x | EV / Sales 2027 * | 8.68x |
| Free-Float |
99.79% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript : Vertex Pharmaceuticals Incorporated
| 1 day | -85.47% | ||
| 1 week | -4.24% | ||
| Current month | -4.24% | ||
| 1 month | +1.29% | ||
| 3 months | +16.25% | ||
| 6 months | +13.48% | ||
| Current year | +7.62% |
| 1 week | 83.9 |  | 88.92 |
| 1 month | 79.2 | | 89.01 |
| Current year | 65.18 | | 89.01 |
| 1 year | 62.2 | | 89.01 |
| 3 years | 52.29 | | 93.56 |
| 5 years | 30.22 | | 93.56 |
| 10 years | 20.29 | | 93.56 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 53 | 2020-03-31 | |
Charles Wagner
DFI | Director of Finance/CFO | 57 | 2019-04-09 |
Sean Daughtry
CTO | Chief Tech/Sci/R&D Officer | - | 2024-02-29 |
| Director | Title | Age | Since |
|---|---|---|---|
Bruce Sachs
BRD | Director/Board Member | 66 | 1997-12-31 |
Jeffrey Leiden
CHM | Chairman | 70 | 2012-04-30 |
Sangeeta Bhatia
BRD | Director/Board Member | 57 | 2015-06-17 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -85.47% | -4.24% | - | - | 138B | |
| -2.21% | -3.11% | +52.16% | +91.64% | 1,024B | |
| -2.22% | -0.76% | +51.08% | +67.61% | 663B | |
| -2.99% | -4.31% | +18.59% | +66.94% | 453B | |
| -0.88% | +0.86% | +29.77% | +36.54% | 349B | |
| -10.89% | -14.63% | +9.27% | +26.87% | 295B | |
| -1.38% | -0.72% | -0.79% | +9.50% | 253B | |
| -10.08% | -10.26% | +40.32% | +51.55% | 236B | |
| -2.32% | -0.65% | -15.84% | -56.91% | 206B | |
| -2.88% | -2.19% | +26.54% | +92.95% | 187B | |
| Average | -11.79% | +0.01% | +23.46% | +42.97% | 407.48B | |
| Weighted average by Cap. | -5.44% | -1.04% | +32.70% | +57.27% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 13.25B 67.36B 11.39B 10.72B 9.78B 18.25B 1,256B 18.35B 127B 49.13B 642B 49.76B 48.67B 2,043B | 14.5B 73.69B 12.46B 11.73B 10.7B 19.97B 1,374B 20.07B 139B 53.76B 702B 54.44B 53.25B 2,235B |
| Net income | 2.53B 12.89B 2.18B 2.05B 1.87B 3.49B 240B 3.51B 24.29B 9.4B 123B 9.52B 9.31B 391B | 4.83B 24.56B 4.15B 3.91B 3.57B 6.66B 458B 6.69B 46.3B 17.91B 234B 18.14B 17.75B 745B |
| Net Debt | -5.3B -26.95B -4.56B -4.29B -3.91B -7.3B -503B -7.34B -50.81B -19.66B -257B -19.91B -19.47B -817B | -8.25B -41.95B -7.1B -6.67B -6.09B -11.37B -782B -11.43B -79.09B -30.6B -400B -30.99B -30.31B -1,272B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-08 | R$84.20 | -4.03% | 266 |
| 26-09-04 | R$87.74 | -1.33% | 800 |
| 26-09-03 | R$88.92 | +1.13% | 518 |
| 26-09-02 | R$87.93 | -0.22% | 2 |
| 26-09-01 | R$88.12 | +0.22% | 3 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- VRTX Stock
- VRTX34 Stock
Select your edition
All financial news and data tailored to specific country editions
